Barclays PLC Takes $75,000 Position in OnKure Therapeutics (NASDAQ:OKUR)
Barclays PLC bought a new position in shares of OnKure Therapeutics (NASDAQ:OKUR – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 8,741 shares of the company’s stock, valued at approximately $75,000. Other large investors have also added to or reduced their stakes in the company. Aldebaran Capital LLC bought a new […]
Barclays PLC bought a new position in shares of OnKure Therapeutics (NASDAQ:OKUR – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 8,741 shares of the company’s stock, valued at approximately $75,000. Other large investors have also added to or reduced their stakes in the company. Aldebaran Capital LLC bought a new […]
